| Literature DB >> 27585647 |
Wallax Augusto Silva Ferreira1, Danilo do Rosário Pinheiro1, Carlos Antonio da Costa Junior1, Symara Rodrigues-Antunes1, Mariana Diniz Araújo1, Mariceli Baia Leão Barros1, Adriana Corrêa de Souza Teixeira1, Thamirys Aline Silva Faro1, Rommel Rodriguez Burbano2, Edivaldo Herculano Correa de Oliveira3, Maria Lúcia Harada1, Bárbara do Nascimento Borges1.
Abstract
Glioblastomas, also known as glioblastoma multiforme (GBM), are the most aggressive and malignant type of primary brain tumor in adults, exhibiting notable variability at the histopathological, genetic and epigenetic levels. Recently, epigenetic alterations have emerged as a common hallmark of many tumors, including GBM. Considering that a deeper understanding of the epigenetic modifications that occur in GBM may increase the knowledge regarding the tumorigenesis, progression and recurrence of this disease, in this review we discuss the recent major advances in GBM epigenetics research involving histone modification, glioblastoma stem cells, DNA methylation, noncoding RNAs expression, including their main alterations and the use of epigenetic therapy as a valid option for GBM treatment.Entities:
Keywords: DNA methylation; astrocytomas; biomarkers; brain tumors; cancer; epigenetic regulation; genetic; glioblastoma; gliomas; targeted therapy
Mesh:
Substances:
Year: 2016 PMID: 27585647 DOI: 10.2217/epi-2016-0040
Source DB: PubMed Journal: Epigenomics ISSN: 1750-192X Impact factor: 4.778